Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Functional Protein

Recombinant Mouse IL7 Protein, No tag (Active)

Catalog #:   AMC96801 Specific References (50) DATASHEET
Applications: Bioactivity, ELISA, Immunogen, SDS-PAGE, WB
Expression system: E. coli
Accession: P10168
Protein length: Glu26-Ile154
Overview

Catalog No.

AMC96801

Biological activity

Measured in a cell proliferation assay using antibody against CD3-activated human peripheral blood mononuclear cell (PBMC). The ED50 for this effect is typically 0.4-4 ng/mL.

Expression system

E. coli

Species

Mus musculus (Mouse)

Protein length

Glu26-Ile154

Nature

Recombinant

Endotoxin level

<1 EU/μg of the protein by the LAL method.

Purity

>90% as determined by SDS-PAGE.

Accession

P10168

Applications

Bioactivity, ELISA, Immunogen, SDS-PAGE, WB

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

IL-7, Interleukin-7, IL7,

Data Image
References

Dose Optimization of rhIL-7-hyFc for Patients With Lymphopenia Using a Neonatal Fc Receptor-Mediated Recycling-Based and Target-Mediated Drug Disposition Pharmacokinetic Model., PMID:40396986

Interleukin-7 enhances recruitment of MDSCs by regulating MCP-1 via JAK1/STAT3 signaling pathway in non-small cell lung cancer., PMID:40374882

IL-7 in autoimmune diseases: mechanisms and therapeutic potential., PMID:40313966

Endogenous IL-7 Variation in Relation to Lymphocyte Subtypes in Septic Patients., PMID:40005375

A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19., PMID:39903535

IL-7 secreted by keratinocytes induces melanogenesis via c-kit/MAPK signaling pathway in Melan-a melanocytes., PMID:39825949

Optimized BCMA/CS1 bispecific TRuC-T cells secreting IL-7 and CCL21 robustly control multiple myeloma., PMID:39776916

The Role of PD-1/PD-L1 and IL-7 in Lymphocyte Dynamics and Sepsis Progression: A Biomarker Study in Critically Ill Patients., PMID:39684323

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment., PMID:39593187

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer., PMID:39576210

A novel strategy of co-expressing CXCR5 and IL-7 enhances CAR-T cell effectiveness in osteosarcoma., PMID:39450160

Membrane-bound IL-7 immobilized by the CD8 transmembrane region improves efficacy of CD19 CAR-T cell therapy., PMID:39443955

IL-7-dependent and -independent lineages of IL-7R-dependent human T cells., PMID:39352394

IL-4, IL-7, IL-9, NT, NRP1 May Be Useful Markers in the Diagnosis of Endometrial Cancer., PMID:39334861

Therapeutic Efficacy of IL7/CCL19-Expressing CAR-T Cells in Intractable Solid Tumor Models of Glioblastoma and Pancreatic Cancer., PMID:39240078

Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain., PMID:39186002

An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade., PMID:39142716

APOE ε4-associated downregulation of the IL-7/IL-7R pathway in effector memory T cells: Implications for Alzheimer's disease., PMID:39129310

Concentration of IL-1β, IL-7, IL-12, IL-17, CX3CL1, ITAC and relation with the seizure severity and sudden unexpected death in epilepsy patient., PMID:39096615

Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma., PMID:39093440

Interleukin-7 Risk Allele, Lymphocyte Counts, and Autoantibodies for Prediction of Risk of Immune-Related Adverse Events in Patients Receiving Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma., PMID:39079513

rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors., PMID:39043602

Expression pattern of serum interleukin-7 in elderly septic patients and its prognostic value for predicting short-term mortality., PMID:38795605

IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy., PMID:38744277

High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome., PMID:38114349

PELI2 regulates early B-cell progenitor differentiation and related leukemia via the IL-7R expression., PMID:38058209

Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells., PMID:38033053

The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review., PMID:37566474

IL-7 germline variant: setting the stage for immune-related adverse events., PMID:36748568

In patients with primary Sjögren's syndrome innate-like MAIT cells display upregulated IL-7R, IFN-γ, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells., PMID:36505431

IL-7 and IL-7R in health and disease: An update through COVID times., PMID:36503870

IL-7/IL7R axis dysfunction in adults with severe community-acquired pneumonia (CAP): a cross-sectional study., PMID:35907923

The role of interleukin‑7 serum level as biological marker in breast cancer: a cross‑sectional, observational, and analytical study., PMID:35794603

Association between IL-7 and primary Sjögren's syndrome: A single-center study and a systematic scoping review., PMID:35405597

Interleukin-7 and soluble Interleukin-7 receptor levels in type 1 diabetes - Impact of IL7RA polymorphisms, HLA risk genotypes and clinical features., PMID:35063672

Proteomic analysis in primary T cells reveals IL-7 alters T cell receptor thresholding via CYTIP/cytohesin/LFA-1 localisation and activation., PMID:35015072

CD127 imprints functional heterogeneity to diversify monocyte responses in inflammatory diseases., PMID:35015026

Selective dependence on IL-7 for antigen-specific CD8 T cell responses during airway influenza infection., PMID:34997007

The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines., PMID:34956167

Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS., PMID:34739914

Interleukin-7-dependent nonclassical monocytes and CD40 expression are affected in children with type 1 diabetes., PMID:34625948

IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant., PMID:34603318

Interleukin-7 Is Associated with Clinical and Pathological Activities in Immunoglobulin A Nephropathy and Protects the Renal Proximal Tubule Epithelium from Cellular Fibrosis., PMID:34596812

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)., PMID:34452927

TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma., PMID:34445415

Identification of new IL-7Rα small-molecule agonists: a multi-computational approach., PMID:34431428

Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model., PMID:34389619

IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin., PMID:34325726

Internal Disulfide Bonding and Glycosylation of Interleukin-7 Protect Against Proteolytic Inactivation by Neutrophil Metalloproteinases and Serine Proteases., PMID:34276694

Expression Level and Significance of Tim-3 in CD4+ T Lymphocytes in Peripheral Blood of Patients with Coronary Heart Disease., PMID:34236813

Datasheet
$ 360
Product specifications
50 μg 360 100 μg 580

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Mouse IL7 Protein, No tag (Active) [AMC96801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only